Old Web
English
Sign In
Acemap
>
authorDetail
>
Juergen Fleck
Juergen Fleck
Novartis
Pasireotide
Endocrinology
Internal medicine
Acromegaly
Octreotide
5
Papers
234
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pasireotide long-acting release maintains biochemical control in patients with acromegaly: results from the extension of randomised, Phase III, PAOLA study
2015
A. Colao
Marcello Bronstein
Thierry Brue
Mihail Coculescu
Laura De Marinis
Maria Fleseriu
Mirtha Guitelman
Vyacheslav Pronin
G. Raverot
Ilan Shimon
Juergen Fleck
Albert Kandra
Alberto M Pedroncelli
Monica R Gadelha
Show All
Source
Cite
Save
Citations (0)
Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial
2014
The Lancet Diabetes & Endocrinology
Mônica R. Gadelha
Marcello D. Bronstein
Thierry Brue
Mihail Coculescu
Maria Fleseriu
Mirtha Guitelman
Vyacheslav Pronin
G. Raverot
Ilan Shimon
Kayo Kodama Lievre
Juergen Fleck
Mounir Aout
Alberto M Pedroncelli
Annamaria Colao
Show All
Source
Cite
Save
Citations (228)
OR7-7: Pasireotide LAR provides superior efficacy over octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: a phase III, multicenter, randomized study (PAOLA)
2014
Growth Hormone & Igf Research
M. Fleseriu
Mônica R. Gadelha
M. D Bronstein
T. Brue
Mihail Coculescu
Mirtha Guitelman
Vyacheslav Pronin
G. Raverot
I. Shimon
Juergen Fleck
Mounir Aout
Alberto M Pedroncelli
A. Colao
Show All
Source
Cite
Save
Citations (3)
Pasiréotide LP montre une efficacité supérieure versus octréotide LP et lanréotide Autogel chez les patients avec une acromégalie non contrôlée
2014
Annales D Endocrinologie
G. Raverot
B. Vergès
A. Tabarin
D. Drui
P. Caron
P. Chanson
Juergen Fleck
Mounir Aout
Alberto M Pedroncelli
T. Brue
Show All
Source
Cite
Save
Citations (0)
Pasireotide LAR demonstrates superior efficacy versus octreotide LAR and lanreotide ATG in patients with inadequately controlled acromegaly: results from a phase III, multicentre, randomized study (PAOLA)
2014
Growth Hormone & Igf Research
Monica R Gadelha
Marcello Bronstein
Thierry Brue
Mihail Coculescu
Maria Fleseriu
Mirtha Guitelman
Vyacheslav Pronin
G. Raverot
Ilan Shimon
Kayo Kodama Lievre
Juergen Fleck
Mounir Aout
Alberto M Pedroncelli
Annamaria Colao
Show All
Source
Cite
Save
Citations (3)
1